Global /United States /Healthcare /Medical Devices /IART
chevron_leftBack
Integra LifeSciences Holdings Corp. logo

Integra LifeSciences Holdings Corp.

IART
NASDAQ: IART Delayed
10.08USD -6.2%
As of 13 June 2026, Integra LifeSciences Holdings Corp. has a market cap of $784.49M USD, ranking #12169 globally and #2331 in the United States. It ranks #1108 in the Healthcare sector, and #215 in the Medical Devices industry.
Global Rank
12169
Country Rank
2331
Sector Rank
1108
Industry Rank
215
Key Stats
Market Cap
$784.49MUSD
Enterprise Value
$2.57BUSD
Revenue (TTM)
$1.64BUSD
EBITDA (TTM)
$297.75MUSD
Net Income (TTM)
-$516.47MUSD
EBITDA Margin
18%
Profit Margin
-32%
Forward PE
4.3
PS Ratio
0.5
PB Ratio
0.8
EV/EBITDA
8.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Mojdeh Poul open_in_new
Employees
4,427
Founded
1989
IPO
16 Aug 1995
Website
integralife.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-6.2% -6.2% 9.6% -7.4% -35% -40%

News

Loading...

IART Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
IART
Integra Lifesciences Holdings Corp
ISIN: US4579852082
Shares Out.:
77.797M1 Shares Float: 66.563M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
10.08 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Integra LifeSciences Holdings Corp.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. It also offers after-market services; surgical headlamps and instrumentation; instrument patterns and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company provides treatment of acute wounds, such as burns; chronic wounds, including diabetic foot ulcers; and surgical tissue repair applications, including hernia reinforcement, tendon protection, and peripheral nerve repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, and nerve and tendon repair products. Additionally, the company is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. It offers its products directly through various salesforces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was formerly known as Integra LifeSciences Corp. and changed its name to Integra LifeSciences Holdings Corporation in June 1995. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
22K%
25.8
$160.73B
20K%
56.7
$159.07B
20K%
25.6
DHR
$126.55B
16K%
34.7
SYK
$120.69B
15K%
38.3
$84.93B
11K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
13K%
22.2
$97.46B
84.32B EUR
12K%
36.7
7741
$61.41B
9.83T JPY
8K%
40.0
$45.47B
39.34B EUR
6K%
18.7
ALC
$36.38B
28.99B CHF
5K%
37.9
$30.06B
203.66B CNY
4K%
26.0
chevron_leftBack